Ligand-Stimulated Downregulation of the Alpha Interferon Receptor: Role of Protein Kinase D2

REFERENCES

• Aaronson, D. S., and C. M. Horvath. 2002. A road map for those who don't know JAK-STAT. Science 296:1653–1655.
   PubMed Web of Science ®Google Scholar
• Bhattacharya, S., et al. 2010. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. J. Biol. Chem. 285:2318–2325.
   PubMed Web of Science ®Google Scholar
• Bossard, C., D. Bresson, R. S. Polishchuk, and V. Malhotra. 2007. Dimeric PKD regulates membrane fission to form transport carriers at the TGN. J. Cell Biol. 179:1123–1131.
   PubMed Web of Science ®Google Scholar
• Coccia, E. M., G. Uze, and S. Pellegrini. 2006. Negative regulation of type I interferon signaling: facts and mechanisms. Cell. Mol. Biol. (Noisy-le-grand) 52:77–87.
   PubMedGoogle Scholar
• Davis, G. L. 2001. Current treatment for chronic hepatitis C. Rev. Gastroenterol. Disord. 1:59–72.
   PubMedGoogle Scholar
• Di Bernardo, M. C., et al. 2008. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40:1204–1210.
   PubMed Web of Science ®Google Scholar
• Dikic, I. 2003. Mechanisms controlling EGF receptor endocytosis and degradation. Biochem. Soc. Trans. 31:1178–1181.
   PubMed Web of Science ®Google Scholar
• Dikic, I., and S. Giordano. 2003. Negative receptor signalling. Curr. Opin. Cell Biol. 15:128–135.
   PubMed Web of Science ®Google Scholar
• Doppler, H., P. Storz, J. Li, M. J. Comb, and A. Toker. 2005. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J. Biol. Chem. 280:15013–15019.
   PubMedGoogle Scholar
• Du, C., M. Jaggi, C. Zhang, and K. C. Balaji. 2009. Protein kinase D1-mediated phosphorylation and subcellular localization of beta-catenin. Cancer Res. 69:1117–1124.
   PubMedGoogle Scholar
• Du, Z., et al. 2007. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J. Cell. Biochem. 102:1087–1094.
   PubMed Web of Science ®Google Scholar
• Dull, T., et al. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463–8471.
   PubMed Web of Science ®Google Scholar
• Essers, M. A., et al. 2009. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458:904–908.
   PubMed Web of Science ®Google Scholar
• Fuchs, S. Y., A. Chen, Y. Xiong, Z. Q. Pan, and Z. Ronai. 1999. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin. Oncogene 18:2039–2046.
   PubMedGoogle Scholar
• Goldman, L. A., et al. 1999. Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis. J. Interferon Cytokine Res. 19:15–26.
   PubMedGoogle Scholar
• Gschwendt, M., et al. 1996. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase C isoenzymes. FEBS Lett. 392:77–80.
   PubMed Web of Science ®Google Scholar
• Hilton, D. J. 1999. Negative regulators of cytokine signal transduction. Cell. Mol. Life Sci. 55:1568–1577.
   PubMedGoogle Scholar
• Hinchliffe, K. A., and R. F. Irvine. 2006. Regulation of type II PIP kinase by PKD phosphorylation. Cell. Signal. 18:1906–1913.
   PubMedGoogle Scholar
• Huangfu, W. C., and S. Y. Fuchs. 2010. Ubiquitination-dependent regulation of signaling receptors in cancer. Genes Cancer 1:725–734.
   PubMedGoogle Scholar
• Hutti, J. E., et al. 2004. A rapid method for determining protein kinase phosphorylation specificity. Nat. Methods 1:27–29.
   PubMed Web of Science ®Google Scholar
• Jaggi, M., et al. 2005. E-cadherin phosphorylation by protein kinase D1/protein kinase Cμ is associated with altered cellular aggregation and motility in prostate cancer. Cancer Res. 65:483–492.
   PubMed Web of Science ®Google Scholar
• Jamora, C., et al. 1999. Gbetagamma-mediated regulation of Golgi organization is through the direct activation of protein kinase D. Cell 98:59–68.
   PubMedGoogle Scholar
• Jin, J., et al. 2003. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17:3062–3074.
   PubMed Web of Science ®Google Scholar
• Khan, O., et al. 2002. Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosis. CNS Drugs 16:563–578.
   PubMed Web of Science ®Google Scholar
• Kirkwood, J. 2002. Cancer immunotherapy: the interferon-alpha experience. Semin. Oncol. 29:18–26.
   PubMed Web of Science ®Google Scholar
• Kumar, K. G., et al. 2007. Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J. Cell Biol. 179:935–950.
   PubMed Web of Science ®Google Scholar
• Kumar, K. G., J. J. Krolewski, and S. Y. Fuchs. 2004. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor. J. Biol. Chem. 279:46614–46620.
   PubMed Web of Science ®Google Scholar
• Kumar, K. G., et al. 2003. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J. 22:5480–5490.
   PubMed Web of Science ®Google Scholar
• Larner, A., and N. C. Reich. 1996. Interferon signal transduction. Biotherapy 8:175–181.
   PubMedGoogle Scholar
• Liu, J., et al. 2009. Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signaling. Mol. Cell. Biol. 29:6401–6412.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al. 2009. Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe 5:72–83.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al. 2008. Ligand-independent pathway that controls stability of interferon alpha receptor. Biochem. Biophys. Res. Commun. 367:388–393.
   PubMed Web of Science ®Google Scholar
• Lu, L., et al. 2008. NS3 protein of hepatitis C virus regulates cyclooxygenase-2 expression through multiple signaling pathways. Virology 371:61–70.
   PubMedGoogle Scholar
• Marijanovic, Z., J. Ragimbeau, K. G. Kumar, S. Y. Fuchs, and S. Pellegrini. 2006. TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem. J. 397:31–38.
   PubMedGoogle Scholar
• McKendry, R., et al. 1991. High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons. Proc. Natl. Acad. Sci. U. S. A. 88:11455–11459.
   PubMed Web of Science ®Google Scholar
• Mihailovic, T., et al. 2004. Protein kinase D2 mediates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+ human myeloid leukemia cells. Cancer Res. 64:8939–8944.
   PubMed Web of Science ®Google Scholar
• Nishikawa, K., A. Toker, F. J. Johannes, Z. Songyang, and L. C. Cantley. 1997. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:952–960.
   PubMed Web of Science ®Google Scholar
• Parisien, J. P., J. F. Lau, J. J. Rodriguez, C. M. Ulane, and C. M. Horvath. 2002. Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J. Virol. 76:4190–4198.
   PubMedGoogle Scholar
• Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 5:375–386.
   PubMed Web of Science ®Google Scholar
• Rozengurt, E., O. Rey, and R. T. Waldron. 2005. Protein kinase D signaling. J. Biol. Chem. 280:13205–13208.
   PubMed Web of Science ®Google Scholar
• Rybin, V. O., J. Guo, and S. F. Steinberg. 2009. Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916. J. Biol. Chem. 284:2332–2343.
   PubMedGoogle Scholar
• Sharlow, E. R., et al. 2008. Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone. J. Biol. Chem. 283:33516–33526.
   PubMed Web of Science ®Google Scholar
• Sharma, S., et al. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151.
   PubMed Web of Science ®Google Scholar
• Sidorenko, S. P., et al. 1996. Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5:353–363.
   PubMedGoogle Scholar
• Spiegelman, V. S., et al. 2000. Wnt/beta-catenin signaling induces the expression and activity of betaTrCP ubiquitin ligase receptor. Mol. Cell 5:877–882.
   PubMed Web of Science ®Google Scholar
• Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227–264.
   PubMed Web of Science ®Google Scholar
• Storz, P., H. Doppler, F. J. Johannes, and A. Toker. 2003. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J. Biol. Chem. 278:17969–17976.
   PubMedGoogle Scholar
• Storz, P., and A. Toker. 2003. Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway. EMBO J. 22:109–120.
   PubMed Web of Science ®Google Scholar
• Sturany, S., et al. 2002. Mechanism of activation of protein kinase D2(PKD2) by the CCK(B)/gastrin receptor. J. Biol. Chem. 277:29431–29436.
   PubMedGoogle Scholar
• Velazquez, L., M. Fellous, G. R. Stark, and S. Pellegrini. 1992. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70:313–322.
   PubMed Web of Science ®Google Scholar
• Waldron, R. T., and E. Rozengurt. 2000. Oxidative stress induces protein kinase D activation in intact cells. Involvement of Src and dependence on protein kinase C. J. Biol. Chem. 275:17114–17121.
   PubMed Web of Science ®Google Scholar
• Waldron, R. T., J. P. Whitelegge, K. F. Faull, and E. Rozengurt. 2007. Identification of a novel phosphorylation site in c-jun directly targeted in vitro by protein kinase D. Biochem. Biophys. Res. Commun. 356:361–367.
   PubMedGoogle Scholar
• Wang, Q. J. 2006. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol. Sci. 27:317–323.
   PubMed Web of Science ®Google Scholar
• Yeaman, C., et al. 2004. Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat. Cell Biol. 6:106–112.
   PubMedGoogle Scholar
• Zugaza, J. L., R. T. Waldron, J. Sinnett-Smith, and E. Rozengurt. 1997. Bombesin, vasopressin, endothelin, bradykinin, and platelet-derived growth factor rapidly activate protein kinase D through a protein kinase C-dependent signal transduction pathway. J. Biol. Chem. 272:23952–23960.
   PubMedGoogle Scholar